ClinicalTrials.gg
Enrolling by invitationNCT06856707Updated Oct 5, 2026

MIRA Registry Study: Post Market Surveillance Using the MIRA Surgical System

An observational study in Colon Procedures and Bowel Resection, sponsored by Virtual Incision Corporation. Enrolling by invitation at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Virtual Incision Corporation · Observational

How we know

Updated Oct 5, 2026Title changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Sex
All
01

Study summary

The purpose of the MIRA Surgical System Registry is to accumulate and evaluate real world evidence experience as part of post-market surveillance using the MIRA Surgical System.

The studies primary goals are to:

  • To evaluate the performance of the MIRA Surgical System
  • To evaluate the Device Safety profile
02

Conditions studied

  • Colon Procedures
  • Bowel Resection
03

In context

Lead sponsor

Virtual Incision Corporation is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients indicated for minimally invasive surgery using the MIRA Surgical System.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing surgery using the MIRA Surgical System
  • Subject is able to provide
  • Subject is available for post operative follow up visit through 30 days

Exclusion criteria

Exclusion Criteria:

  • Has or is participating in another clinical trial which may confound study results
  • In the opinion of the investigator, patient is not likely to complete post-operative care and/or return for standard follow-up.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Target follow-up
30 Days
Patient registry
Yes

Groups and cohorts

  • Surgical

    Patients undergoing surgery with the MIRA Surgical System

    Device: Use of the MIRA Surgical System during surgery

Interventions

  • DeviceUse of the MIRA Surgical System during surgery

    Use of the MIRA Surgical System to perform robotically assisted colorectal surgery.

    Also known as: Robotically Assisted Surgery

06

What researchers measure

Primary outcomes

  1. Performance of MIRA Surgical System

    Successful completion of the surgical procedure using the MIRA Surgical System without conversion to open surgery (Yes/No).

    Time frame: From time of procedure through completion of the surgical procedure

  2. Device Safety

    Incidence of Device related adverse events and Unanticipated Device Effects

    Time frame: From time of surgery using the MIRA Surgical System through 30 days following surgical procedure

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Study design is to evaluate cumulative database of all patients who have undergone surgery using the MIRA Surgical System.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for May 2028, 36 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2025
First posted
Mar 4, 2025
StartActual
Apr 30, 2025
Primary completionEst.
May 28, 2028
CompletionEst.
Jun 2028
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Title
MIRA Registry Study→MIRA Registry Study: Post Market Surveillance Using the MIRA Surgical System
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Title MIRA Registry Study→MIRA Registry Study: Post Market Surveillance Using the MIRA Surgical System
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06856707
Lead sponsor
Virtual Incision Corporation
Responsible party
Sponsor
First posted
Mar 4, 2025
Start date
Apr 30, 2025
Primary completion
May 28, 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Oct 5, 2026

Study contacts

Piet Hinoul, M.D.
study chair · Virtual Incision Corporation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion